Zobrazeno 1 - 10 of 46 pro vyhledávání: '"J P Aymard"'
1
Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis
Autor: C. Colin, P. Vergnon, A. M. Jullien, S. Excoffier, Y. Matillon, C. Trepo, J. P. Aymard, D. Bastit, M. L. Bidet, R. Breviere, F. Chenais, F. Hau, D. Houssay, A. Mercadier, P. Maisonneuve, M. Lambert, C. Waller, D. Boudart, C. Cotte, M. H. Elghouzzi, C. Janot, M. Daudet, M. Menault, M. Montcharmont, W. Smilovici, C. Fretz, R. Follana, M. Doillon, J. C. Petit, P. Herve, B. Loyer, B. Mattlinger
Publikováno v: European Journal of Clinical Microbiology & Infectious Diseases. 16:220-227
The current approach to screening for hepatitis C and non-A, non-B, non-C hepatitis in French blood transfusion centers involves a combination of a transaminase assay and tests for antibodies to hepatitis B core antigen (anti-HBc) and antibodies to h
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::54e1bc63a96e21889804645a0470aa96
https://doi.org/10.1007/bf01709585
Zobrazit plný text záznamu
2
Thein vitroeffect of amodiaquine on bone marrow granulocyte-macrophage progenitor cells from normal subjects
Autor: C. Wioland, F. Streiff, J. P. Aymard, R. Ferry, P. Netter
Publikováno v: Fundamental & Clinical Pharmacology. 6:1-4
Summary— Amodiaquine is used for antimalarial prophylaxis and treatment and has been associated with neutropenia and agranulocytosis in man. The effect of the drug on the in vitro growth of bone marrow human myeloid progenitor cells (GM-CFU) was te
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9ee69d7359b0bd0a5a5258ca0d0a10d
https://doi.org/10.1111/j.1472-8206.1992.tb00086.x
Zobrazit plný text záznamu
3
[Seroprevalence of hepatitis C antibodies among blood donors. Study of second generation ELISA and RIBA tests and surrogate markers]
Autor: J P, Aymard, C, Botte, P, Contal, C, Janot, F, Streiff
Publikováno v: Pathologie-biologie. 41(2)
Between March and November 1991, prevalence of hepatitis C antibodies was evaluated in 60,960 blood donors from the North-East of France. Using a second generation ELISA, 424 donors (0.69%) were reactive, with no significant difference between males
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6b2215ffbe0631c342d2cba1e6b4367c
https://pubmed.ncbi.nlm.nih.gov/8327265
Zobrazit plný text záznamu
4
[Serum antibodies to hepatitis C virus: analysis of risk factors of seropositivity in a population of blood donors in metropolitan France]
Autor: P, Maisonneuve, J P, Aymard, J M, Lemaire, A, Baillet, C, Janot
Publikováno v: La Revue de medecine interne. 12(6)
Risk factors were analyzed in a group of 117 blood donors seropositive for hepatitis C virus antibody. One risk factor, at least, was found in 63 (53.8%) subjects. Frequently encountered risk factors were 1) travels in developing countries (31/117);
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d1f4b8e4314229e16262512a72ba369a
https://pubmed.ncbi.nlm.nih.gov/1724323
Zobrazit plný text záznamu
6
[Familial hypobetalipoproteinemia. Familial study of 4 cases]
Autor: G, Gay, M, Pessah, M E, Bouma, J F, Roche, J P, Aymard, I, Beucler, L P, Aggerbeck, R, Infante
Publikováno v: La Revue de medecine interne. 11(4)
A familial study of four cases with hypobetalipoproteinemia is reported. Three members are heterozygous and one is homozygous. This congenital fat malabsorption in homozygous state is commonly associated with an absence of serum apoprotein B and LDL.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c194a85f58b00bc703bb154790e7674e
https://pubmed.ncbi.nlm.nih.gov/2096430
Zobrazit plný text záznamu
7
[Serum antibodies against hepatitis C: study of 4,100 blood donors from the northeast of France]
Autor: J P, Aymard, C, Janot, J C, Adjizian, C, Tamisier, J C, Humbert, M, Billuart, F, Streiff
Publikováno v: Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine. 33(4)
Between June 1989 and February 1990 the prevalence of antibodies to hepatitis C virus (anti-HCV) was studied in blood donations from 4,100 donors tested in north east France. 37 samples were found reactive for anti-HCV (prevalence of anti-HCV: 0.90%)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::55a3a90628b6c29b13ead3407c688f39
https://pubmed.ncbi.nlm.nih.gov/2171543
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje